VRNA - Verona Pharma PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRNA is currently covered by 8 analysts with an average price target of $97.48. This is a potential upside of $13.48 (16.05%) from yesterday's end of day stock price of $84.

Verona Pharma PLC ADR's activity chart (see below) currently has 88 price targets and 89 ratings on display. The stock rating distribution of VRNA is 79.17% BUY and 20.83% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.62% with an average time for these price targets to be met of 834.5 days.

Highest price target for VRNA is $160, Lowest price target is $107, average price target is $117.6.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 13-Jul-2025. First documented stock forecast 21-May-2017.

Currently out of the existing stock ratings of VRNA, 19 are a BUY (79.17%), 5 are a HOLD (20.83%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$107

$19 (21.59%)

$90

3 months 17 days ago
(13-Jul-2025)

25/26 (96.15%)

$2.33 (2.23%)

288

Hold

$34

3 months 21 days ago
(09-Jul-2025)

4/4 (100%)

$18.41 (118.09%)

697

Hold

$107

$19 (21.59%)

$138

3 months 21 days ago
(09-Jul-2025)

4/7 (57.14%)

$2.15 (2.05%)

113

Hold

$107

$19 (21.59%)

$72

3 months 22 days ago
(08-Jul-2025)

13/14 (92.86%)

$2.23 (2.13%)

431

Hold

$107

$19 (21.59%)

$110

3 months 22 days ago
(08-Jul-2025)

2/4 (50%)

$2.23 (2.13%)

690

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRNA (Verona Pharma PLC ADR) average time for price targets to be met?

On average it took 834.5 days on average for the stock forecasts to be realized with a an average price target met ratio 81.62

Which analyst has the current highest performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?

TIAGO FAUTH

Which analyst has the most public recommendations on VRNA (Verona Pharma PLC ADR)?

Tiago Fauth works at WELLS FARGO and has 8 price targets and 5 ratings on VRNA

Which analyst is the currently most bullish on VRNA (Verona Pharma PLC ADR)?

Yasmeen Rahimi with highest potential upside - $72

Which analyst is the currently most reserved on VRNA (Verona Pharma PLC ADR)?

Adam Walsh with lowest potential downside - -$80

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?